Cell and gene therapies (CGT) are at the forefront of a new era of medicine and have the potential to improve patients´ lives in unprecedented ways. However, there are significant challenges to overcome, from scientific, logistical and regulatory issues to key questions of access and affordability and not least the wider impact on patients and society at large.

What does the future hold for transformative therapies, and can we overcome the hurdles around their use? Join EHFG and CSL Behring for this exciting webinar that will offer thought-provoking expert inputs and explore the impact and implications of these disruptive therapies. Register now!

Webinar speakers:

• Bertalan Mesko, Director, The Medical Futurist Institute
• Diane Kleinermans, President of the Commission of Drugs Reimbursement, National Institute for Health and Disability Insurance, Belgium 
• Paige Bischoff, Senior Vice President, Global Public Affairs, Alliance for Regenerative Medicine
• Dan Hart, Consultant haematologist, The Royal London Hospital Haemophilia Centre
• Ilona G. Reischl, Quality Assessor – Biologics, Austrian Medicines and Medical Devices Agency (AGES/MEA)
• Moderated by Vivienne Parry, Head of Engagement, Genomics England

Further speakers to be announced!

If you have any questions for the speakers, you can ask them during the event via the webinar Q&A function - or email us in advance at info@ehfg.org or tweet with #transformingtomorrow @GasteinForum @CSLBehring